Impact of Genomic Variation of NFE2L2 (rs6706649) on Serum Glyoxalase-1 Levels in A Sample of Iraqi Type 2 Diabetic Patients with Retinopathy
DOI:
https://doi.org/10.31351/vol33iss(4SI)pp159-168Keywords:
Oxidative stress, NFE2L-2 gene polymorphism, GLO-1, MG, diabetic retinopathyAbstract
Nuclear factor erythroid-2-related factor-2 (NFE2L-2) is one important endogenous anti -oxidative stress signal pathway. Single nucleotide polymorphism (SNP) or genetic variants of NFE2L-2 may be accountable for the genesis of diabetic retinopathy. Glyoxalase-1 (Glo-1) is the rate-limiting enzyme in the detoxification of methylglyoxal (MG) into D-lactate. The activity of GLO1 is regulated by the transcription factor NFE2L2.The goal of this study is to ascertain whether there is an association between the rs6706649 of NFE2L2 gene variant with serum GLO-1 levels in a group of Iraqi diabetic patients diagnosed with diabetic retinopathy (DR). This study included ninety patients diagnosed with type 2 diabetes mellitus (48 females and 42 males), with ages ranging from 40 to 80 years. The participants were partitioned into two the following groups: Group A; 60 patients with type 2 diabetes mellitus diagnosed with DR (among them 29 patients with non-proliferative diabetic retinopathy (NPDR) and 31 patients with proliferative diabetic retinopathy (PDR)) and Group B: 30 patients without evidence of DR (DWR) considered as a control group were enrolled in the study. A non-significant difference in genotyping and allele carriage frequencies of rs6706649 (G/A) SNP between DR and DWR groups. Also, there was a non-significant difference between PDR and NPDR patients' groups in relation to the different genotypes and alleles of rs6706649 (G/A) of NFE2L2 gene. However, the changing from the wild genotype (GG) to mutant (AA) and heretogynotypes (GA) had significant positive correlation with the increased serum levels of GLO-1 and significant negative correlation with serum level of methylglyoxal (MG) in patients with diabetic retinopathy. Furthermore, pentosidine, carboxymethyl lysine (CML), GLO-1 and MG levels were significantly higher in DR when compared to DWR groups. The A mutant allele of rs6706649 (G >A) had significant positive correlation with the increased serum GLO-1 levels in DR group. Meanwhile, DR group had increased serum MG, GLO-1, pentosidine and CML levels. Hence, these biomarkers can serve as prognostic indicators for diabetic retinopathy.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Ali IA, Ali SH. Impact of osteocalcin level on vascular calcification in type 2 diabetics in relation to fibroblast growth factor-23 (FGF-23). Iraqi J Pharm Sci. 2018 Dec 6:42-54.
Kadhim SA, Saleh ES, Jaafer AD. Assessment of Serum Levels of Advanced Oxidation Protein Products in Type 2 Diabetic Patients with and without Retinopathy Taking Different Antidiabetic Treatments. Iraqi J Pharm Sci. 2023 Sep 27;32(2):74-82.
Kadhim SA, Saleh ES, Jaafar AD. Assessment of Serum Levels of the WNT Pathway Antagonist (Dickkopf-1) in a Sample of Type 2 Diabetic Patients with Retinopathy using Two Groups of Antidiabetics. International Journal of Drug Delivery Technology. 2023;13(2):488-493
Sarah H Mhaibes, Shatha H. Ali, Biomarkers of Oxidative Stress in Diabetic Microvascular Complications. Iraqi J Pharm Sci.,2024;33 in press
Bokhary K, Aljaser F, Abudawood M, et al. Role of oxidative stress and severity of diabetic retinopathy in type 1 and type 2 diabetes. Ophthalmic Research. 2021 Jan 26;64(4):613-21.
Kang Q, Dai H, Jiang S, Yu L. Advanced glycation end products in diabetic retinopathy and phytochemical therapy. Frontiers in Nutrition. 2022 Nov 18; 9:1037186.
Aragonès G, Rowan S, G Francisco S, et al. Glyoxalase system as a therapeutic target against diabetic retinopathy. Antioxidants. 2020 Oct 30;9(11):1062.
Cepas, V.; Collino, M.; Mayo, J.C., et al. Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases. Antioxidants 2020, 9, 142.
Ghanem AA, Elewa A, Arafa LF. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy. Eur J Ophthalmol. 2011;21(1):48-54.
Shaheed HS, Ali SH, Association of Carnosinase-1 Gene Polymorphism with Serum Carnosine and Carnosinease-1 Isoform Levels in Type 2 Diabetics with Cardiovascular Diseases in Iraq. Al-Rafidain J Med Sci.,2023;4:109-17.
Umapathy D, Krishnamoorthy E, Mariappanadar V, et al. Increased levels of circulating (TNF-α) is associated with (-308G/A) promoter polymorphism of TNF-α gene in Diabetic Nephropathy. International journal of biological macromolecules. 2018 Feb 1; 107:2113-21.
Cho HY. Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2. Oxidative medicine and cellular longevity. 2013 Oct;2013.
He Y, Zhou C, Huang M, et al. Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators. Biomedicine & Pharmacotherapy. 2020 Nov 1; 131:110663.
Solomon SD, Goldberg MF, ETDRS grading of diabetic retinopathy: still the gold standard? Ophthalmic Res. 2019;62(4):190–5.
Care D. Care in diabetes—2022. Diabetes care.,2022 Jan 1;45: S17.
Kropp M, Golubnitschaja O, Mazurakova A, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023;14(1):21-42.
Mjwara M, Khan M, Kruse CH, et al. Significance of HbA1c levels in diabetic retinopathy extremes in South Africa. South African Medical Journal. 2021;111(9):886-90.
Zhao H, Zhang LD, Liu LF, et al. Blood levels of glycated hemoglobin, D-dimer, and fibrinogen in diabetic retinopathy. Diabetes, Metabolic Syndrome and Obesity. 2021 Jun 2:2483-8.
Ameen IA, Saleh E, Mhaibes SH, et al. Evaluation of some inflammatory cytokines and Glycated hemoglobin in uncontrolled type 2 diabetes mellitus with nephropathy. Indian J. Forensic Med. Toxicol.,2020;14(2):1628-32.
Salih BH, Ali SH, Allehibi KI. Serum Aldosterone Levels in Patients With Diabetic Nephropathy in Relation to Vascular Calcification. Iraqi Journal of Pharmaceutical Sciences. 2019 Jun 11;28(1):53-63.
Błaszkiewicz M, Walulik A, Florek K, et al. Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy—A Review. Biomedicines. 2023; 11(11):2951.
Ghanem AA, Elewa A, Arafa LF. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy. European journal of ophthalmology. 2011 Jan;21(1):48-54.
Kerkeni M, Saïdi A, Bouzidi H, et al. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes and Vascular Disease Research. 2013 May;10(3):239-45.
Choudhuri S, Dutta D, Sen A, et al. Role of N–epsilon-carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus. Molecular vision. 2013; 19:100.
R. Mancino, D. DiPierro, C. Varesi et al., “Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy,” Molecular Vision.2011;17: 1298–1304.
Hernández C., Porta M., Bandello F., et al. The usefulness of serum biomarkers in the early stages of diabetic retinopathy: Results of the EUROCONDOR clinical trial. J. Clin. Med. 2020; 9:1233.
Aragonès G, Rowan S, Francisco SG, et al. The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy. Cells. 2021; 10(8):1852.
Fosmark DS, Torjesen PA, Kilhovd BK, et al. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabolism. 2006 Feb 1;55(2):232-6.
X. Kong, M.Z. Ma, K. Huang, et al. Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes.J. Diabetes, .2014;6(6): 535-540
M. Akagawa, A. Mori, K. Sakamoto, et al. Methylglyoxal impairs beta2-adrenoceptor-mediated vasodilatory mechanisms in rat retinal arterioles.Biol. Pharm. Bull. 2018;41 (2): 272-276
Xu X, Sun J, Chang X, et al. Genetic variants of nuclear factor erythroid‐derived 2‐like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China. Journal of Cellular and Molecular Medicine. 2016 Nov;20(11):2078-88.
Zazueta C, Jimenez-Uribe AP, Pedraza-Chaverri J, et al. Genetic Variations on Redox Control in Cardiometabolic Diseases: The Role of Nrf2. Antioxidants (Basel). 2022;11(3):507.
Rasul A, Rashid A, Waheed P, et al. Expression analysis of glyoxalase I gene among patients of diabetic retinopathy. Pakistan Journal of Medical Sciences. 2018 Jan;34(1):139.
Patke VG, Saroj SR. The role of enzymes of the glyoxalase system in relation to complications in type II diabetes mellitus. International Journal of Research in Medical Sciences. 2015 Feb;3(2):440.
Ahmed Ft, Ali Sh, Al Gawwam Ga, Correlation Between Integrin Alpha-4 Gene Polymorphisms and Failure To Respond To Natalizumab Therapy In Iraqi Multiple Sclerosis Patients. Farmacia.,2023;71(3):563-572
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
